Composite cardiovascular risk and BMI affected comparative profiles of BIAsp 30 + metformin vs BIAsp 30 monotherapy: a MERIT post-hoc analysis

We assessed whether comparative efficacy and safety of biphasic insulin aspart 30 (BIAsp 30) plus metformin versus BIAsp 30 monotherapy differed for patients with type 2 diabetes mellitus (T2DM) inadequately controlled with oral antidiabetic drugs with different cardiovascular risk scores and differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lixin, Chang, Baocheng, Chen, Li, Yang, Liyong, Liu, Yu, Feng, Bo, He, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893025/
https://www.ncbi.nlm.nih.gov/pubmed/33602996
http://dx.doi.org/10.1038/s41598-021-83410-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893025/
https://www.ncbi.nlm.nih.gov/pubmed/33602996
http://dx.doi.org/10.1038/s41598-021-83410-x

Ejemplares similares